Viacom International Inc.’s copyright and trademark infringement suits against Cablevision Systems Corp. are pending, Cablevision disclosed in its August 9, 2011, Form 10-Q filing with the U.S. Securities and Exchange…
A two-count declaratory judgment action for non-infringement of U.S. Patent Nos. 6,916,941 and 7,420,069, which are listed in the U.S. Food and Drug Administration’s Orange Book for Lexapro, filed by…
Patent infringement actions filed by Pfizer Inc. against against Teva USA with respect to Detrol LA (tolterodine) and against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva USA, with…
A patent infringement suit filed by Pfizer Inc. against Impax Laboratories, Inc. relating to Detrol (tolterodine) is pending.
In April 2011, Impax notified the Company that it had filed an abbreviated…
A patent infringement suit filed by Pfizer Inc. against Torrent Pharmaceuticals Ltd. relating to Detrol LA (tolterodine) is pending.
In June 2011, Torrent notified the Company that it had filed an…
Patent infringement actions filed by Pfizer Inc. against Apotex Inc., Apotex Corp. and Teva USA relating to Relpax (eletriptan) are pending.
In June 2010, the Company received notices from Apotex Inc.…
Federal trademark claims in a complaint filed by Wathne Imports, Ltd. against Polo Ralph Lauren Corp. in 2005 have been withdrawn.
On Aug. 19, 2005, Wathne Imports, Ltd., Polo’s then domestic…
Forest Laboratories Inc. disclosed that on March 11, 2011, the Federal Circuit affirmed a ruling invalidating Infosint S.A.’s patent.
In April 2006, an action was commenced in the United States District…
Advanced Micro Devices Inc.’s customers face a patent infringement suit brought by Graphics Properties Holdings, Inc.
On Nov. 16, 2010, GPHI filed suit against several AMD customers alleging infringement of U.S.…
Pfizer Inc. is pursuing patent infringement actions against Apotex Inc., Apotex Corp. and Mylan Pharmaceuticals Inc.
In July 2010, the Company received notices from Apotex and from Mylan that they had…